Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 12;58(12):1833.
doi: 10.3390/medicina58121833.

Kawasaki Disease with Hepatobiliary Manifestations

Affiliations

Kawasaki Disease with Hepatobiliary Manifestations

Siti Aisyah Suhaini et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Kawasaki Disease (KD) incidence has been on the rise globally throughout the years, particularly in the Asia Pacific region. KD can be diagnosed based on several clinical criteria. Due to its systemic inflammatory nature, multi-organ involvement has been observed, making the diagnosis of KD more challenging. Notably, several studies have reported KD patients presenting with hepatobiliary abnormalities. Nonetheless, comprehensive data regarding the hepatobiliary manifestations of KD are limited in Malaysia, justifying a more in-depth study of the disease in this country. Thus, in this article, we aim to discuss KD patients in Malaysia with hepatobiliary manifestations. Materials and Methods: A total of six KD patients with hepatobiliary findings who presented at Hospital Canselor Tuanku Muhriz (HCTM) from 2004 to 2021 were selected and included. Variables including the initial presenting signs and symptoms, clinical progress, laboratory investigations such as liver function test (LFT), and ultrasound findings of hepatobiliary system were reviewed and analyzed. Results: Out of these six KD patients, there were two patients complicated with hepatitis and one patient with gallbladder hydrops. Different clinical features including jaundice (n = 3) and hepatomegaly (n = 4) were also observed. All patients received both aspirin and intravenous immunoglobulin (IVIG) as their first-line treatment and all of them responded well to IVIG. The majority of them (n = 5) had a complete recovery and did not have any cardiovascular and hepatobiliary sequelae. Conclusions: Despite KD mostly being diagnosed with the classical clinical criteria, patients with atypical presentations should always alert physicians of KD as one of the possible differential diagnoses. This study discovered that hepatobiliary manifestations in KD patients were not uncommon. More awareness on the epidemiology, diagnosis, and management of KD patients with hepatobiliary manifestations are required to allow for the initiation of prompt treatment, thus preventing further complications.

Keywords: Kawasaki disease; complications; gallbladder hydrops; hepatitis; hepatobiliary manifestation; hepatomegaly; hyperbilirubinemia.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest in this manuscript.

References

    1. Kim G.B. Reality of Kawasaki Disease Epidemiology. Korean J. Pediatr. 2019;62:292–296. doi: 10.3345/kjp.2019.00157. - DOI - PMC - PubMed
    1. de Graeff N., Groot N., Ozen S., Eleftheriou D., Avcin T., Bader-Meunier B., Dolezalova P., Feldman B.M., Kone-Paut I., Lahdenne P., et al. European Consensus-Based Recommendations for the Diagnosis and Treatment of Kawasaki Disease—The SHARE Initiative. Rheumatology. 2019;58:672–682. doi: 10.1093/rheumatology/key344. - DOI - PubMed
    1. Sánchez-Manubens J., Bou R., Anton J. Diagnosis and Classification of Kawasaki Disease. J. Autoimmun. 2014;48–49:113–117. doi: 10.1016/j.jaut.2014.01.010. - DOI - PubMed
    1. McCrindle B.W., Rowley A.H., Newburger J.W., Burns J.C., Bolger A.F., Gewitz M., Baker A.L., Jackson M.A., Takahashi M., Shah P.B., et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2017;135:e927–e999. doi: 10.1161/CIR.0000000000000484. - DOI - PubMed
    1. Duarte R., Cisneros S., Fernandez G., Castellon D., Cattani C., Melo C.A., Apocada A. Kawasaki Disease: A Review with Emphasis on Cardiovascular Complications. Insights Imaging. 2010;1:223–231. doi: 10.1007/s13244-010-0035-6. - DOI - PMC - PubMed

MeSH terms